Jane Street’s Loncar China BioPharma ETF CHNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-19,335
| Closed | -$276K | – | 6295 |
|
|
2023
Q3 | $276K | Buy |
19,335
+7,357
| +61% | +$105K | ﹤0.01% | 4135 |
|
|
2023
Q2 | $194K | Buy |
+11,978
| New | +$194K | ﹤0.01% | 4595 |
|
|
2023
Q1 | – | Sell |
-29,839
| Closed | -$560K | – | 6497 |
|
|
2022
Q4 | $560K | Buy |
29,839
+2,928
| +11% | +$55K | ﹤0.01% | 3265 |
|
|
2022
Q3 | $386K | Buy |
+26,911
| New | +$386K | ﹤0.01% | 3919 |
|
|
2022
Q1 | – | Sell |
-61,266
| Closed | -$1.64M | – | 6385 |
|
|
2021
Q4 | $1.64M | Buy |
61,266
+24,430
| +66% | +$654K | ﹤0.01% | 2137 |
|
|
2021
Q3 | $1.37M | Buy |
+36,836
| New | +$1.37M | ﹤0.01% | 2297 |
|
|
2021
Q2 | – | Sell |
-20,956
| Closed | -$773K | – | 5955 |
|
|
2021
Q1 | $773K | Sell |
20,956
-20,410
| -49% | -$753K | ﹤0.01% | 2827 |
|
|
2020
Q4 | $1.35M | Sell |
41,366
-7,275
| -15% | -$237K | ﹤0.01% | 1823 |
|
|
2020
Q3 | $1.49M | Buy |
48,641
+20,148
| +71% | +$619K | ﹤0.01% | 1436 |
|
|
2020
Q2 | $876K | Sell |
28,493
-28,891
| -50% | -$888K | ﹤0.01% | 2052 |
|
|
2020
Q1 | $1.3M | Buy |
+57,384
| New | +$1.3M | ﹤0.01% | 1357 |
|
|
2019
Q3 | – | Sell |
-12,166
| Closed | -$270K | – | 4155 |
|
|
2019
Q2 | $270K | Buy |
+12,166
| New | +$270K | ﹤0.01% | 2849 |
|